FDA Inspection 1208772 — Matrix Pharmacorp Private Limited

Matrix Pharmacorp Private Limited — FEI 3002785310

The FDA completed an inspection of Matrix Pharmacorp Private Limited on May 5, 2023 in Gaitula Chodavaram. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 5, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Gaitula Chodavaram (India)